Pinealon

Pinealon (Glu–Asp–Arg) is presented as a short peptide bioregulator developed within the Khavinson research program and studied for neuroprotective and cognition-support effects. In the protocol, Pinealon is described as crossing cellular and nuclear membranes and interacting directly with DNA, thereby modulating gene expression in brain tissue. Mechanistically, the page highlights reduction of reactive oxygen species accumulation, reduced necrotic cell death in neurons, and modulation of cell-cycle signaling toward proliferative/repair pathways under stress. These effects are framed as contributing to neuroprotection in models of oxidative stress and ischemic injury and to improved cognitive performance in animal learning and memory paradigms. The page also summarizes reported clinical experience (within the cited literature) in brain-injury and cerebral disorder contexts, where improvements in memory, attention, cognitive function, and emotional stability were described with daily courses. Overall, the mechanism is positioned as gene-regulatory neuroprotection plus antioxidant/anti-apoptotic support, with generally good tolerability.